SCHEMBL4604785

SCHEMBL4604785

CCCCNC(=O)Nc1ccccc1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 9/20 0.87
ALDH1A1 P00352 3/20 0.87
HTT P42858 2/20 0.87
KDM4E B2RXH2 1/20 0.68
LMNA P02545 1/20 0.65
GHSR Q92847 1/20 0.64
POLB P06746 1/20 0.64
HDAC1 Q13547 2/20 0.62
HDAC8 Q9BY41 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.60
HDAC2 Q92769 1/20 0.60
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
NPC1 O15118 1/20 0.58
MITF O75030 1/20 0.58
MAPT P10636 1/20 0.58
RAB9A P51151 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7722626 0.95 EPHX1 (0.97) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL5020899 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL4138192 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL422504 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL11671083 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL10599308 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL813735 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL4603476 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL17119069 0.93 EPHX1 (1.00) EPHX1ALDH1A1HTTKDM4ELMNA
SCHEMBL14424453 0.90 EPHX1 (0.72) EPHX1ALDH1A1HTTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227999-A1 Heterogeneous Supported Catalytic Carbamate Process MOLZAHN DAVID C 2008-09-18 US claimed
EP-1943214-A2 HETEROGENEOUS SUPPORTED CATALYTIC CARBAMATE PROCESS Dow Gloval Technologies Inc. (US) 2008-07-16 EP claimed
WO-2007015852-A2 HETEROGENEOUS SUPPORTED CATALYTIC CARBAMATE PROCESS DOW GLOBAL TECHNOLOGIES INC. (US) 2007-02-08 WO claimed
CN-119462433-A Synthesis method of N, N' -disubstituted asymmetric urea and chlorazuron 内蒙古工业大学 2025-02-18 CN disclosed
EP-4446310-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND Asahi Kasei Kabushiki Kaisha (JP) 2024-10-16 EP disclosed
CN-118382612-A Method for producing blocked isocyanate compound and method for producing isocyanate compound 旭化成株式会社 2024-07-23 CN disclosed
WO-2024058800-A1 HIGH DUCTILITY, HIGH MODULUS AND PHTHALATE FREE IMPACT RESISTANT PROPYLENE COPOLYMER FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2024-03-21 WO disclosed
WO-2023106377-A1 METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND 旭化成株式会社 2023-06-15 WO disclosed
US-20200223871-A1 Arginase Inhibitors and Methods of Use ASTRAZENECA AB (SE) 2020-07-16 US disclosed
CN-109843963-A Isocyanate composition, method for producing isocyanate polymer, and isocyanate polymer 旭化成株式会社 2019-06-04 CN disclosed
US-20190127395-A1 Arginase Inhibitors and Methods of Use ASTRAZENECA AB (SE) 2019-05-02 US disclosed
EP-0507616-A1 Process for the preparation of trisubstituted ureas by reductive carbonylation ARCO Chemical Technology, L.P. (US) 1992-10-07 EP disclosed
US-4888321-A SUBBING AND RECORDING LAYERS EACH CONTAINING HEAT FUSIBLE MATERIAL WITH DEFINED MELTING POINT FUJI PHOTO FILM CO., LTD. (JP) 1989-12-19 US disclosed
US-4567287-A Preparation of carbamates from organic carbonates and aromatic ureas THE UPJOHN CO. (US) 1986-01-28 US disclosed
US-4533929-A ANIONIC SURFACTANTS AS ANTIFOGGING AGENTS; DIETHYLHEXYL SULFOSUCCINATE FUJI PHOTO FILM CO., LTD. (JP) 1985-08-06 US disclosed
US-4520377-A COLOR FORMING LAYER COMO/SED OF ELECTRON DONATING COLORLESS DYE, ELECTRON ACCEPTING COMPOUND, NAPHTHOL UREA AND/OR URETHANE DERIVATIVE FUJI PHOTO FILM CO., LTD. (JP) 1985-05-28 US disclosed
US-4444863-A UREA COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1984-04-24 US disclosed
US-4401717-A CONTAINING A CHROMOGEN, A PHENOL LAND A UREA OR CARBAMATE; THERMOGRAPHY FUJI PHOTO FILM CO., LTD. (JP) 1983-08-30 US disclosed
US-4085268-A Disubstituted s-triazines ARMSTRONG CORK COMPANY (US) 1978-04-18 US disclosed
US-3936484-A Production of isocyanates from substituted ureas ATLANTIC RICHFIELD COMPANY (US) 1976-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227999-A1 Heterogeneous Supported Catalytic Carbamate Process CPS1, CAT, CA7 EPHX1 4546/4885ALDH1A1 4027/4885HTT 925/4885
US-20200223871-A1 Arginase Inhibitors and Methods of Use ARG1, ARG2, NOS2 EPHX1 687/4885ALDH1A1 407/4885HTT 4776/4885
US-20190127395-A1 Arginase Inhibitors and Methods of Use ARG1, ARG2, NOS2 EPHX1 687/4885ALDH1A1 407/4885HTT 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.